TickerFacts.

Unicycive Therapeutics, Inc. (UNCY): Operating Income

Annual figures by period end, from SEC filings.

-$29.52M
Year ended 2025-12-31
-$33.13M
Trailing 12 months to 2026-06-30
2020-12-31: -$2.02M2021-12-31: -$8.98M2022-12-31: -$18.05M2023-12-31: -$20.77M2024-12-31: -$32.12M2025-12-31: -$29.52M-$29.52M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$29.52Mn/m2026-03-30, From 2025-01-01
2024-12-31-$32.12Mn/m2026-03-30, From 2024-01-01
2023-12-31-$20.77Mn/m2025-03-31, From 2023-01-01
2022-12-31-$18.05Mn/m2024-03-28, From 2022-01-01
2021-12-31-$8.98Mn/m2023-03-31, From 2021-01-01
2020-12-31-$2.02Mn/a2022-03-31, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Unicycive Therapeutics, Inc. (UNCY)2025-12-31-$29.52Mn/m
Vistagen Therapeutics, Inc. (VTGN)2026-03-31-$72.13Mn/m
Coya Therapeutics, Inc. (COYA)2025-12-31-$22.56Mn/m
NextCure, Inc. (NXTC)2025-12-31-$57.62Mn/m
Opus Genetics, Inc. (IRD)2025-12-31-$38.60Mn/m
Akari Therapeutics Plc (AKTX)2025-12-31-$17.27Mn/m
Atossa Therapeutics, Inc. (ATOS)2025-12-31-$37.14Mn/m
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31-$12.19Mn/m
Actinium Pharmaceuticals, Inc. (ATNM)2025-12-31-$36.25Mn/m

Compare UNCY, VTGN, COYA, NXTC side by side · Screen every company in Pharmaceutical Preparations ↗